| Name | Title | Contact Details |
|---|
Emerging Health Information Technology is a Yonkers, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
API WELLNESS CENTER is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Heidelberg Engineering is a Smithfield, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
York Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in York, ME. To find more information about York Hospital, please visit www.yorkhospital.com
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.